Changing paradigms in the diagnosis and management of bronchiectasis

American Journal of Respiratory Medicine

Volumn 1, Issue 5, 2002, Pages 339-347

  Greenstone, Michael ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BETA LACTAM ANTIBIOTIC; BROMHEXINE; BRONCHODILATING AGENT; CEFTAZIDIME; CORTICOSTEROID; GENTAMICIN; MUCOLYTIC AGENT; OXYGEN; OXYTETRACYCLINE; PENICILLIN G; PLACEBO; THEOPHYLLINE; TOBRAMYCIN;

AIRWAY OBSTRUCTION; ARTICLE; ASSISTED VENTILATION; BRONCHIECTASIS; BRONCHOGRAPHY; CLINICAL PROTOCOL; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; EMPYEMA; EVIDENCE BASED MEDICINE; HEMOPTYSIS; HUMAN; LUNG ABSCESS; LUNG ASPERGILLOSIS; LUNG SURGERY; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; OXYGEN THERAPY; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; TREATMENT INDICATION;

EID: 0041856075     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256627     Document Type: Article

References (71)

1. Keistinen T, Saynajakangas O, Tuuponen T, et al. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 1997; 10: 2784-7
2. Nicotra MB, Rivera M, Dale AM, et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995; 108: 955-61
3. O'Brien C, Guest PJ, Hill ST, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55: 635-42
4. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204
5. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999; 116: 1063-74
6. Grenier P, Maurice F, Musset D, et al. Bronchiectasis: assessment by thin-section CT. Radiology 1986; 161: 95-9
7. Munro NC, Cooke JC, Currie DC, et al. Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production. Thorax 1990; 45: 135-9
8. Smith IE, Jurianns E, Diederich S, et al. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 1996; 51: 914-8
9. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000; 55: 198-204
10. Lynch DA, Newell J, Hale V, et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. Am J Roentgenol 1999; 173: 53-8
11. Cartier Y, Kavanagh PV, Johkoh T, et al. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. Am J Roentgenol 1999; 173: 47-52
12. De Gracia J, Rodrigo MJ, Morell F, et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med 1996; 153: 650-5
13. Roifman CM, Levison H, Gelfand EW, et al. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987; I: 1075-7
14. Angus RM, Davies ML, Cowan MD, et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994; 49: 586-9
15. Rayner CF, Rutman A, Dewar A, et al. Ciliary disorientation alone as a cause of primary ciliary dyskinesia syndrome. Am J Respir Crit Care Med 1996; 153: 1123-9
16. Karadag B, James AJ, Gultekin E, et al. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 1999; 13: 1402-5
17. Tsang KW, Leung R, Fung PC, et al. Exhaled and sputum nitric oxide in bronchiectasis. Chest 2002; 121: 88-94
18. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162: 1277-84
19. Jones P, Milan S. Randomised controlled trials in airways disease. Lung and Asthma Information Agency Factsheet 2001/3. London: St George's Hospital Medical School, 2001
20. Jones A, Rowe BH. Bronchopulmonary hygeine physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review. Heart Lung 2000; 29: 125-35
21. Cecins NM, Jenkins SC, Pengelly J, et al. The active cycle of breathing techniques: to tip or not to tip? Respir Med 1999; 93: 660-5
22. Ellis DA, Thornley PE, Wightman AJ, et al. Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. Thorax 1981; 36: 659-64
23. Munro NC, Han LY, Currie DC, et al. Radiological evidence of progression of bronchiectasis. Respir Med 1992; 86: 397-401
24. Ip M, Lauder IJ, Wong WY, et al. Multivariate analysis of factors affecting pulmonary function in bronchiectasis. Respiration 1993; 60: 45-50
25. Evans SA, Turner SM, Bosch BJ, et al. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996; 9: 1601-4
26. Cole PJ. Inflammation a two edged sword: the model of bronchiectasis. Eur J Respir Dis 1986; 69 Suppl. 147: 6-15
27. Wilson CB, Jones PW, O'Leary CL et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998; 12: 820-4
28. Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1889-93
29. Loukides S, Horvath I, Wodehouse T, et al. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998; 158: 991-4
30. Medical Research Council. Subcommittee of the antibiotics clinical trials (non-tuberculous): prolonged antibiotic treatment of severe bronchiectasis. BMJ 1957; 2: 255-9
31. Hill SL, Burnett D, Hewetson KA, et al. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med 1988; 66: 163-73
32. Currie DC, Garbett ND, Chan KL, et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med 1990; 76: 799-816
33. Tsang KWT, Ho P-I, Chan K-N, et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 1999; 13: 361-4
34. Koh YY, Lee MH, Sun YH, et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double blind placebo controlled study. Eur Respir J 1997; 10: 994-9
35. Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000; 162: 481-5
36. Orriols R, Roig J, Ferrer J, et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999; 93: 476-80
37. Evans DJ, Bara A, Greenstone M. Continuous antibiotics for purulent bronchiectasis: a systematic review of the evidence. Thorax 2001; 56 Suppl. II: 52
38. Cole PJ, Roberts DE, Davies SF, et al. A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother 1983; 11: 109-13
39. Taylor RFH, Hodson ME. Cystic fibrosis: antibiotic prescribing practices in the United Kingdom and Eire. Respir Med 1993; 87: 535-9
40. Cheng K, Smyth RL, Govan JRW, et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-42
41. Barza M, Ioannidis JPA, Cappellari JC, et al. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312: 338-44
42. Winter RJD, George RJD, Deacock SJ, et al. Self administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet 1984; 23: 1338-9
43. Wolter JM, Bowler SD, Nolan PJ, et al. Home intravenous therapy in cystic fibrosis: a prospective randomised trial examining clinical, quality of life and cost aspects. Eur Respir J 1997; 10: 896-900
44. Touw DJ, Brimicombe RW, Hodson ME, et al. Inhalation of antibiotics in cystic fibrosis. Eur Respir J 1995; 8: 1594-604
45. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725-6
46. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment at time of initial colonisation with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration in pulmonary function in patients with cystic fibrosis. Pediatr Pulmonol 1997; 23: 330-5
47. Houtmeyers E, Gosselink R, Gayan-Ramirez G, et al. Effects of drugs on mucus clearance. Eur Respir J 1999; 14: 452-67
48. Olivieri D, Ciaccia A, Marangio E, et al. Role of bromhexine in exacerbations of bronchiectasis. Respiration 1991; 58: 117-21
49. Wills PJ, Wodehouse T, Corkery K, et al. Short-term recombinant human DNase in bronchiectasis. Am J Respir Crit Care Med 1996; 154: 413-7
50. O'Donnell AE, Barker AF, Ilowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase. Chest 1998; 113: 1329-34
51. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322: 1271-4
52. Gaga M, Bentley AM, Humbert M, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53: 685-91
53. Elborn JS, Johnston B, Allen F, et al. Inhaled steroids in patients with bronchiectasis. Respir Med 1992; 86: 121-4
54. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998; 158: 723-7
55. Auerbach HS, Williams M, Kirkpatrick JA, et al. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985; II: 686-8
56. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997; 10: 2376-9
57. Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax 1984; 39: 179-84
58. Hassan AJ, Saadiah S, Roslan H, et al. Bronchodilator responses to inhaled beta 2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology 1999; 4: 423-6
59. Newall C, Henson M, Mc Connell AK, et al. The effects of pulmonary rehabilitation in patients with bronchiectasis. Eur Respir J 2000; 16 Suppl. 31: 330
60. Agasthian T, Deschamps C, Trastek VF, et al. Surgical management of bronchiectasis. Ann Thorac Surg 1996; 62: 976-80
61. Currie DC, Saverymutta SH, Peters AM, et al. Indium-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis. Lancet 1987; I: 1335-9
62. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus report. Chest 1999; 116: 521-34
63. Gaucouin A, Desrues B, Lena H, et al. Long-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study. Eur Respir J 1996; 9: 1246-50
64. Benhamou D, Muir JF, Raspaud C, et al. Long-term efficiency of home nasal mask ventilation in patients with diffuse bronchiectasis and severe chronic respiratory failure. Chest 1997; 112: 1259-66
65. Leger P, Bedicam JM, Cornette A, et al. Nasal intermittent positive pressure ventilation: long term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994; 105: 100-5
66. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995; 50: 604-9
67. Rao JN, Forty J, Hasan A, et al. Bilateral lung transplant: the procedure of choice for end-stage septic lung disease. Transpl Proc 2001; 33: 1622-3
68. Beirne PA, Banner N, Khagani A, et al. Lung transplantation for bronchiectasis not due to cystic fibrosis (CF). Thorax 2001; 56 Suppl. III: 53
69. Koyoma H, Geddes DM. Erythromycin and diffuse panbronchiolitis. Thorax 1997; 52: 915-8
70. Barker AF, Bardana EJ. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis 1988; 137: 969-78
71. Fleetham JA. A wake-up call for sleep disordered breathing. BMJ 1997; 314: 839-40